| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2022 | QUICKSILVER BIOSCIENCES INC | 1361 AMSTERDAM AVE | NEW YORK | NY | 10027-2510 | NEW YORK | USA | R44DE030841 | Direct bioelectronic detection of SARS-CoV-2 from saliva using single-molecule field-effect transistor array | 000 | 2 | NIH | 5/27/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2022 | QUICKSILVER BIOSCIENCES INC | 1361 AMSTERDAM AVE | NEW YORK | NY | 10027-2510 | NEW YORK | USA | R44DE030841 | Direct bioelectronic detection of SARS-CoV-2 from saliva using single-molecule field-effect transistor array | 001 | 2 | NIH | 5/20/2024 | $0 |
| | 2024 | 2022 | QUICKSILVER BIOSCIENCES INC | 1361 AMSTERDAM AVE | NEW YORK | NY | 10027-2510 | NEW YORK | USA | R44DE030841 | Direct bioelectronic detection of SARS-CoV-2 from saliva using single-molecule field-effect transistor array | 000 | 2 | NIH | 11/9/2023 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $0 ) |
| | 2023 | 2022 | QUICKSILVER BIOSCIENCES INC | 1361 AMSTERDAM AVE | NEW YORK | NY | 10027-2510 | NEW YORK | USA | R44DE030841 | Direct bioelectronic detection of SARS-CoV-2 from saliva using single-molecule field-effect transistor array | 001 | 2 | NIH | 9/14/2023 | $0 |
| | 2023 | 2021 | QUICKSILVER BIOSCIENCES INC | 1361 AMSTERDAM AVE | NEW YORK | NY | 10027-2510 | NEW YORK | USA | R44DE030841 | Direct bioelectronic detection of SARS-CoV-2 from saliva using single-molecule field-effect transistor array | 000 | 1 | NIH | 9/14/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $447,801 ) |
| | 2022 | 2022 | QUICKSILVER BIOSCIENCES, INC. | 1361 AMSTERDAM AVE STE 340 | NEW YORK | NY | 10027-2510 | NEW YORK | USA | R44DE030841 | Direct bioelectronic detection of SARS-CoV-2 from saliva using single-molecule field-effect transistor array | 000 | 2 | NIH | 2/10/2022 | $447,801 |
| | 2022 | 2021 | QUICKSILVER BIOSCIENCES, INC. | 1361 AMSTERDAM AVE STE 340 | NEW YORK | NY | 10027-2510 | NEW YORK | USA | R44DE030841 | Direct bioelectronic detection of SARS-CoV-2 from saliva using single-molecule field-effect transistor array | 001 | 1 | NIH | 4/20/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $817,335 ) |
| | 2021 | 2021 | QUICKSILVER BIOSCIENCES, INC. | 1361 AMSTERDAM AVE STE 340 | NEW YORK | NY | 10027-2510 | NEW YORK | USA | R44DE030841 | Direct bioelectronic detection of SARS-CoV-2 from saliva using single-molecule field-effect transistor array | 000 | 1 | NIH | 12/21/2020 | $817,335 |
| | 2021 | 2021 | QUICKSILVER BIOSCIENCES, INC. | 1361 AMSTERDAM AVE STE 340 | NEW YORK | NY | 10027-2510 | NEW YORK | USA | R44DE030841 | Direct bioelectronic detection of SARS-CoV-2 from saliva using single-molecule field-effect transistor array | 001 | 1 | NIH | 3/15/2021 | $0 |
|
|
